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Little is known about changes in protein secretion in Pa laboratory and clinical
strains induced by oxygen limitation and their effects on epithelial cells. Here,
we demonstrated that conditioned medium from PAO1 and clinical strain AA2
under aerobiosis induced a statistically signiﬁcant increase of about 2.9 and 4.9
times, respectively of IL-8 and TNF-a mRNA, in CF airway epithelial cells. This
induction was reduced of about 25% when strains were grown under microaer-
obiosis, suggesting that adaptation to microaerobiosis reduces Pa pathogenicity.
Two-dimensional capillary chromatography–tandem mass spectrometry (MudPIT)
identiﬁed 75 polypeptides released by PAO1 and 198 by AA2 in aerobiosis.
Differential expression was observed under microaerobiosis when compared to
aerobiosis with 6 proteins up-regulated in PAO1 and 7 proteins upregulated in
AA2; 4 proteins were downregulated in AA2. 7 proteases were released from AA2
while only 1 from PAO1 with strong down modulation of alkaline metalloprotease
in microaerobiosis by AA2 as conﬁrmed by proteolytic activity assay.
Identiﬁcation of virulence factors might be facilitated by this combined approach
suggesting molecular targets for pharmacological intervention.
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Pseudomonas aeruginosa (PA) is the most important bacterial pathogen in CF
patients. To address the issue of low colonization by PA, we developed a real time
polymerase chain reaction (PCR) in the sputum of CF children characterized either
by the absence of PA colonization (group A; n = 28) or by an PA intermittent
colonization over the last 3 years (group B; n = 19). The results of the PCR
technique were analyzed according to the presence or absence of a concomitant
pulmonary exacerbation as measured by the score of Rosenfeld. During a 1-year, a
total of 61 (groupA) and 29 sputa (groupB) were collected. DNA PA was extracted
from each sample and the PA speciﬁc oprL gene was ampliﬁed by PCR. The
quantiﬁcation was optimized using pure calibrated suspensions of PA.
The use of the PCR technique allowed a detection limit of 15 CFU/mL. In group A,
PCR ampliﬁcation was positive (20 to 600 CFU/mL) in the 3 sputum samples
collected from one patient, in one of the 2−3 sputum samples collected from
3 other patients and in the alone sputum sample collected from one patient. In
group B, PCR ampliﬁcation was positive in all sputa samples from 9 of the 19
intermittently colonized patients (120–23200 CFU/mL). PCR was positive in 11/14
children (78.5%) with pulmonary exacerbation while PCR was negative in 24/32
children (75%) without pulmonary exacerbation (p = 0.0007).
In conclusion, these preliminary results suggest that this PCR technique seems
to be more effective than standard microbiological methods the early detection
and quantiﬁcation of PA in CF patients. Further work is necessary to deﬁne more
accurately the sensitivity and speciﬁcity of this method for early diagnosis and
follow-up of PA colonization.
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There is no doubt that acquisition of Ps.aeruginosa marks a major turning point in
the progression of lung disease in Cystic Fibrosis (CF) sufferers and lengthening
survival times testify to the value of initiating aggressive antibiotic therapy when
colonisation is discovered. Ps.aeruginosa is commonly acquired in childhood but in
young patients the effectiveness of routine microbiological culture is compromised
by the difﬁculty in obtaining good respiratory specimens. We have investigated
whether a real-time PCR method would be more sensitive than conventional
microbial culture for the detection of Ps.aeruginosa in this setting.
Real-time PCR was performed by extracting DNA using the EZ1 BioRobot and
a tissue extraction kit, followed by ampliﬁcation and detection using an ABI
Prism 7000 sequence detector and Taqman probes. Each sample was performed
in duplicate using a reaction which ampliﬁes a speciﬁc Ps. aeruginosa gene target
allowing detection of the DNA of interest. The specimens were also cultured as per
our standard laboratory procedure.
Of the 373 samples tested (from 145 patients) 336 were negative by both culture
and PCR, 11 were positive by both methods but 25 (from 24 patients) were positive
by PCR when culture was negative. The speciﬁcity of the real-time PCR method
was conﬁrmed by sequencing PCR products from positive specimens and matching
to Ps.aeruginosa by BLAST search of the NCBI database.
The use of real-time PCR on cough swabs allowed a signiﬁcant improvement
over routine culture in the detection of Ps.aeruginosa and this study highlights
the beneﬁts modern molecular microbiology techniques may bring to the care of
CF sufferers. Infection control arrangements may have to be re-examined in the
light of results from these more sensitive tests.
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In CF patients acquisition of organisms belonging to the B. cepacia complex (Bcc)
is recognised as a poor prognostic marker. Unfortunately routine diagnostic tests
currently available in clinical microbiology labs do not adequately differentiate
between Bcc and closely related species. Potential Bcc must be conﬁrmed by a
Reference Lab and unnecessary segregation of patients and distress for relatives
may ensue while results are pending. We have developed a real-time PCR method
for detection of Bcc, which is practicable within a routine diagnostic setting.
DNA was extracted using the EZ1 BioRobot. Ampliﬁcation and detection were
achieved using an ABI Prism 7500 sequence detector and Sybr green dye. Each
sample was tested in duplicate using a reaction which ampliﬁes a speciﬁc Bcc gene
target. A dissociation step at the end of the ampliﬁcation protocol determined the
speciﬁcity of the reaction.
Thirty six potential Bcc or related organisms of CF origin which had undergone
precise identiﬁcation at the Reference Lab were available for testing using our
method. DNA extracted from 14 Bcc, genomovars II, IIIA, IIIB, IV and V, tested
positive with a Ct value of between 5 and 8 cycles. No other genomovars were
available. Of 22 closely related organisms including B. gladioli and Ralstonia spp.
none produced positive results.
The primer set used reportedly detects all Bcc strains using standard PCR reactions.
Preliminary results suggest that the real-time method allows rapid, precise recogni-
tion of Bcc genomovars. User-friendliness makes this test ideal for inclusion into
a routine diagnostic service and rapid turn-around of results cannot fail to enhance
patient management. Further work to ensure that less common genomovars can be
detected will conﬁrm the clinical value of this method.
